Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Roca, Maria Serena; Moccia, Tania; Iannelli, Federica; Testa, Cristina; Vitagliano, Carlo; Minopoli, Michele; Camerlingo, Rosa; De Riso, Giulia; De Cecio, Rossella; Bruzzese, Francesca; Conte, Mariarosaria; Altucci, Lucia; Di Gennaro, Elena; Avallone, Antonio; Leone, Alessandra; Budillon, Alfredo

doi:10.1186/s13046-022-02324-2

Journal of Experimental & Clinical Cancer Research

Article metrics
Last updated: Thu, 25 Apr 2024 8:36:36 Z

Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation

Access & Citations

1247

Article Accesses
0

Web of Science
0

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1756-9966

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com